The FDA has approved an expanded indication for the CD3-directed monoclonal antibody teplizumab-mzwv to delay stage 3 type 1 ...
The overall estimated prevalence of incident Type 2 diabetes in COVID-19 was 8.92%. That figure stood at 0.86% for Type 1 ...
A new analysis suggests having diabetes may significantly increase a person's risk of MS, though no evidence was found a ...
New analysis from London Medical Laboratory has revealed up to 18 million UK adults could have prediabetes – which means they are on the verge of developing type 2 diabetes. That’s considerably higher ...
An analysis of patient-reported outcomes (PROs) from the SURPASS-SWITCH trial found that adults with type 2 diabetes who switched from dulaglutide to tirzepatide not only saw stronger improvements in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results